Causes and consequences of increased arterial stiffness in chronic kidney disease patients

被引:89
作者
Gusbeth-Tatomir, Paul [1 ]
Covic, Adrian [1 ]
机构
[1] C I Parhon Univ Hosp, Dialysis & Renal Transplantat Ctr, RO-6600 Iasi, Romania
关键词
arterial stiffness; arteriosclerosis; arterial calcification; end-stage renal disease; chronic kidney disease; hemodialysis; renal transplantation; PULSE-WAVE VELOCITY; STAGE RENAL-DISEASE; AGE-RELATED-CHANGES; CROSS-LINK BREAKER; VASCULAR CALCIFICATION; AORTIC STIFFNESS; BLOOD-PRESSURE; CARDIOVASCULAR RISK; ANGIOTENSIN-II; INDEPENDENT PREDICTOR;
D O I
10.1159/000100905
中图分类号
Q4 [生理学];
学科分类号
071003 [生理学];
摘要
Cardiovascular ( CV) morbidity and mortality is greatly enhanced in patients with chronic kidney disease, compared to the non-renal population. One key element of this high CV burden appears to be arterial stiffness, as an expression of premature vascular aging. Increased arterial stiffness in renal patients may be a consequence of vascular calcification, chronic volume overload, inflammation, endothelial dysfunction, oxidative stress and several other factors. The authors review briefly the main pathophysiological mechanisms leading to reduced arterial compliance. Increased arterial stiffness has significant clinical consequences: isolated systolic hypertension, left ventricular hypertrophy ( and failure), and reduced myocardial perfusion. Better knowledge of the mechanisms of arterial functional and morphologic alteration may help in developing more refined therapeutic strategies aimed to reduce the high CV burden in chronic kidney disease. The potential therapeutic interventions - mainly the use of certain antihypertensive drugs and reduction of vascular calcification - are finally discussed. Copyright (c) 2007 S. Karger AG, Basel.
引用
收藏
页码:97 / 107
页数:11
相关论文
共 105 条
[1]
An advanced glycation endproduct cross-link breaker can reverse age-related increases in myocardial stiffness [J].
Asif, M ;
Egan, J ;
Vasan, S ;
Jyothirmayi, GN ;
Masurekar, MR ;
Lopez, S ;
Williams, C ;
Torres, RL ;
Wagle, D ;
Ulrich, P ;
Cerami, A ;
Brines, M ;
Regan, TJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (06) :2809-2813
[2]
Improvement in blood pressure, arterial stiffness and wave reflections with a very-low-dose perindopril/indapamide combination in hypertensive patient - A comparison with atenolol [J].
Asmar, RG ;
London, GM ;
O'Rourke, ME ;
Safar, ME .
HYPERTENSION, 2001, 38 (04) :922-926
[3]
Quantification of alterations in structure and function of elastin in the arterial media [J].
Avolio, A ;
Jones, D ;
Tafazzoli-Shadpour, M .
HYPERTENSION, 1998, 32 (01) :170-175
[4]
The dietary sodium-blood pressure plot "stiffens" [J].
Bagrov, AY ;
Lakatta, EG .
HYPERTENSION, 2004, 44 (01) :22-24
[5]
Molecular mechanisms of ageing in connective tissues [J].
Bailey, AJ .
MECHANISMS OF AGEING AND DEVELOPMENT, 2001, 122 (07) :735-755
[6]
Aortic collagen, aortic stiffness, and AT(1) receptors in experimental and human hypertension [J].
Benetos, A ;
Safar, ME .
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 1996, 74 (07) :862-866
[7]
Prevention of aortic fibrosis by spironolactone in spontaneously hypertensive rats [J].
Benetos, A ;
Lacolley, P ;
Safar, ME .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1997, 17 (06) :1152-1156
[8]
Determinants of accelerated progression of arterial stiffness in normotensive subjects and in treated hypertensive subjects over a 6-year period [J].
Benetos, A ;
Adamopoulos, C ;
Bureau, JM ;
Temmar, M ;
Labat, C ;
Bean, K ;
Thomas, F ;
Pannier, B ;
Asmar, R ;
Zureik, M ;
Safar, M ;
Guize, L .
CIRCULATION, 2002, 105 (10) :1202-1207
[9]
Impact of aortic stiffness on survival in end-stage renal disease [J].
Blacher, J ;
Guerin, AP ;
Pannier, B ;
Marchais, SJ ;
Safar, ME ;
London, GM .
CIRCULATION, 1999, 99 (18) :2434-2439
[10]
Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease [J].
Blacher, J ;
Guerin, AP ;
Pannier, B ;
Marchais, SJ ;
London, GM .
HYPERTENSION, 2001, 38 (04) :938-942